These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21179888)

  • 1. Optimization protocol for amyloid-β peptides detection in human cerebrospinal fluid using SELDI TOF MS.
    Albertini V; Bruno A; Paterlini A; Lista S; Benussi L; Cereda C; Binetti G; Ghidoni R
    Proteomics Clin Appl; 2010 Mar; 4(3):352-7. PubMed ID: 21179888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment.
    Vanderstichele H; De Meyer G; Andreasen N; Kostanjevecki V; Wallin A; Olsson A; Blennow K; Vanmechelen E
    Clin Chem; 2005 Sep; 51(9):1650-60. PubMed ID: 16020497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of amyloid beta peptides in CSF by surface enhanced MALDI-TOF.
    Takahashi E; Howe A; Vesterqvist O; Lin Z
    Methods Mol Biol; 2012; 818():227-36. PubMed ID: 22083827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum amyloid beta peptides in patients with dementia and age-matched non-demented controls as detected by surface-enhanced laser desorption ionisation-time of flight mass spectrometry (SELDI-TOF MS).
    Frankfort SV; van Campen JP; Tulner LR; Beijnen JH
    Curr Clin Pharmacol; 2008 Sep; 3(3):144-54. PubMed ID: 18781900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic Isoelectric Focusing of Amyloid Beta Peptides Followed by Micropillar-Matrix-Assisted Laser Desorption Ionization-Mass Spectrometry.
    Mikkonen S; Jacksén J; Roeraade J; Thormann W; Emmer Å
    Anal Chem; 2016 Oct; 88(20):10044-10051. PubMed ID: 27619937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid profile of amyloid beta peptides in patients with Alzheimer's disease determined by protein biochip technology.
    Maddalena AS; Papassotiropoulos A; Gonzalez-Agosti C; Signorell A; Hegi T; Pasch T; Nitsch RM; Hock C
    Neurodegener Dis; 2004; 1(4-5):231-5. PubMed ID: 16908995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of MALDI-TOF/TOF Mass Spectrometry Approach for Quantitative Determination of Aspartate Residue Isomerization in the Amyloid-β Peptide.
    Pekov SI; Ivanov DG; Bugrova AE; Indeykina MI; Zakharova NV; Popov IA; Kononikhin AS; Kozin SA; Makarov AA; Nikolaev EN
    J Am Soc Mass Spectrom; 2019 Jul; 30(7):1325-1329. PubMed ID: 31073890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides.
    Bibl M; Gallus M; Welge V; Lehmann S; Sparbier K; Esselmann H; Wiltfang J
    Proteomics Clin Appl; 2012 Apr; 6(3-4):163-9. PubMed ID: 22532452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.
    Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T
    J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
    Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H
    Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi epitope-targeting immunoprecipitation using F(ab') fragments with high affinity and specificity for the enhanced detection of a peptide with matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.
    Kaneko N; Yoshimori T; Yamamoto R; Capon DJ; Shimada T; Sato TA; Tanaka K
    Anal Chem; 2013 Mar; 85(6):3152-9. PubMed ID: 23394179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Kaneko N; Yamamoto R; Sato TA; Tanaka K
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(3):104-17. PubMed ID: 24621957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitomic Characterization of the Specificity of the Anti-Amyloid Aβ Monoclonal Antibodies 6E10 and 4G8.
    Baghallab I; Reyes-Ruiz JM; Abulnaja K; Huwait E; Glabe C
    J Alzheimers Dis; 2018; 66(3):1235-1244. PubMed ID: 30412489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel T719P AbetaPP mutation unbalances the relative proportion of amyloid-beta peptides.
    Ghidoni R; Albertini V; Squitti R; Paterlini A; Bruno A; Bernardini S; Cassetta E; Rossini PM; Squitieri F; Benussi L; Binetti G
    J Alzheimers Dis; 2009; 18(2):295-303. PubMed ID: 19584443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.
    Portelius E; Westman-Brinkmalm A; Zetterberg H; Blennow K
    J Proteome Res; 2006 Apr; 5(4):1010-6. PubMed ID: 16602710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional factorial design for optimization of the SELDI protocol for human adipose tissue culture media.
    Szalowska E; van Hijum SA; Roelofsen H; Hoek A; Vonk RJ; te Meerman GJ
    Biotechnol Prog; 2007; 23(1):217-24. PubMed ID: 17269691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Amyloid-β Deposits in Bovine Brains.
    Vallino Costassa E; Fiorini M; Zanusso G; Peletto S; Acutis P; Baioni E; Maurella C; Tagliavini F; Catania M; Gallo M; Faro ML; Chieppa MN; Meloni D; D'Angelo A; Paciello O; Ghidoni R; Tonoli E; Casalone C; Corona C
    J Alzheimers Dis; 2016; 51(3):875-87. PubMed ID: 26890772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry.
    Gelfanova V; Higgs RE; Dean RA; Holtzman DM; Farlow MR; Siemers ER; Boodhoo A; Qian YW; He X; Jin Z; Fisher DL; Cox KL; Hale JE
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):149-58. PubMed ID: 17584762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined method of immunoaffinity membrane within tubes and MALDI-TOF MS for capturing and analyzing amyloid beta.
    Shimazaki Y; Takatsu Y
    Appl Biochem Biotechnol; 2015 Dec; 177(7):1565-71. PubMed ID: 26384493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.